ランキング価格はじめての方へ
  1. 米国企業
  2. GLOBUS MEDICAL INC

GLOBUS MEDICAL INCGMED

時価総額
$95.6億
PER
77.8倍
サマリーテーブルに戻る
損益計算書バランスシートキャッシュフロー
2012年
12月31日		2013年
12月31日		2014年
12月31日		2015年
12月31日		2016年
12月31日		2017年
12月31日		2018年
12月31日		2019年
12月31日		2020年
12月31日		2021年
12月31日		2022年
12月31日		2023年
12月31日
Net income746992113104107156155102149190123
Research and Development in Process--------24340-
Depreciation and amortization1819222439424253637068145
Amortization of premiums on marketable securities-------1-1-3-5-1
Inventory Write-down687101312102186611
Share-based Compensation557101115222627313353
Amortization of inventory fair value step up-----------72
Allowance for doubtful accounts0101121331-04
Amortization Of Note Fair Value Step Up-----------8
Change in fair value of business acquisition liabilities----3112317517
Share-based Compensation557101115222627313353
Change in deferred income taxes-6-15-46-4814-4-18-22-58
Allowance for doubtful accounts0101121331-04
(Gain)/loss on disposal of assets, net------4-1-1-0-0-2
Change in fair value of business acquisition liabilities----3112317517
Payment of business acquisition related liabilities---------033
Change in deferred income taxes-6-15-46-4814-4-18-22-58
Accounts receivable7101345252218-11265150
Inventories21171819115315050126270
Prepaid expenses and other assets0101-5571211610-1
(Gain)/loss on disposal of assets, net------4-1-1-0-0-2
Accounts payable325-4-010-31-6414-14
Accrued expenses and other liabilities4274-6-18-21571818617
Income taxes payable/receivable-24-5-17-4-1-125-3-0
Payment of business acquisition related liabilities---------033
Net (gain)/loss from foreign currency adjustment------------14
Accounts receivable7101345252218-11265150
Inventories21171819115315050126270
Prepaid expenses and other assets0101-5571211610-1
Accounts payable325-4-010-31-6414-14
Accrued expenses and other liabilities4274-6-18-21571818617
Income taxes payable/receivable-24-5-17-4-1-125-3-0
Net cash provided by/(used in) operating activities779379122172160182172199276178243
Purchases of marketable securities-241251298287393538347224622420101
Maturities of marketable securities-41185189282240278247134228312240
Sales of marketable securities---------110102538
Purchases of property and equipment252425514151607164577478
Acquisition of businesses, net of cash acquired and purchases of intangible and other assets617364976301524333431296
Net cash provided by/(used in) investing activities-31-227-100-151-100-111-193-140-117-376-110303
Payment of business acquisition-related liabilities1111510776978
Proceeds from Stock Options Exercised---5612393172634212
Repurchase of common stock--------105-144226
Payments related to tax withholdings for share-based compensation-----------11
Net cash provided by/(used in) financing activities2411136223324-3954-110-232
Repurchase of common stock--------105-144226
Net cash provided by/(used in) financing activities2411136223324-3954-110-232
Effect of foreign exchange rates on cash--------1-1-12
Net increase/(decrease) in cash and cash equivalents------21-44-46-43317
Income Taxes Paid--------254578101
Accrued purchases of property and equipment--------4577
Stock Issued-----------2,154
Accrued purchases of property and equipment--------4577